Get the Stockscreener App
42.44
2.14%
0.56
Conmed Corp stock is traded at $42.44, with a volume of 11,391.
It is up +2.14% in the last 24 hours and up +6.75% over the past month.
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
See More
Previous Close:
$41.88
Open:
$41.96
24h Volume:
11,391
Relative Volume:
0.02
Market Cap:
$1.34B
Revenue:
$1.32B
Net Income/Loss:
$110.20M
P/E Ratio:
11.98
EPS:
3.5417
Net Cash Flow:
$148.24M
1W Performance:
+3.97%
1M Performance:
+6.75%
6M Performance:
-21.27%
1Y Performance:
-37.63%
1-Day Range:
$41.76
$43.13
1-Week Range:
$40.15
$42.87
52-Week Range:
$38.32
$74.70
Conmed Corp Stock (CNMD) Company Profile
Name
Conmed Corp
Sector
Industry
Phone
727-214-2974
Address
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
43.13 | 1.30B | 1.32B | 110.20M | 148.24M | 3.5417 |
|
ABT
Abbott Laboratories
|
128.91 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.86 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
357.29 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.12 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.02 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-12-25 | Downgrade | Needham | Buy → Hold |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Feb-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-01-24 | Reiterated | Needham | Buy |
| May-22-23 | Initiated | CL King | Buy |
| Mar-27-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-21-23 | Initiated | Wells Fargo | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Oct-06-21 | Upgrade | Needham | Hold → Buy |
| Jul-15-21 | Initiated | UBS | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| Nov-26-19 | Downgrade | Needham | Buy → Hold |
| Nov-12-19 | Initiated | JP Morgan | Overweight |
| Oct-31-19 | Reiterated | Needham | Buy |
| Oct-04-19 | Reiterated | Needham | Buy |
| Aug-22-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Apr-18-19 | Initiated | Stifel | Buy |
| Apr-16-19 | Reiterated | Needham | Buy |
| Jan-23-19 | Reiterated | Needham | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Aug-07-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Apr-26-18 | Reiterated | Needham | Buy |
| Feb-01-18 | Reiterated | Needham | Buy |
| Jul-27-17 | Reiterated | Needham | Buy |
| Apr-27-17 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-27-17 | Reiterated | Needham | Buy |
| Nov-18-16 | Reiterated | Needham | Buy |
| Jul-28-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-28-16 | Reiterated | Needham | Buy |
| Oct-22-15 | Reiterated | Northland Capital | Market Perform |
View All
Conmed Corp Stock (CNMD) Latest News
Is There An Opportunity In CONMED (CNMD) After A 38% One Year Share Price Fall - simplywall.st
CONMED leaders to share company update at J.P. Morgan Healthcare Conference - Stock Titan
What CONMED’s Jan. 28 earnings call could reveal about 2025 - Stock Titan
CONMED (NYSE:CNMD) Cut to Strong Sell at Zacks Research - Defense World
CONMED (NYSE:CNMD) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
Investor Mood: Why CONMED Corporation stock could rally strongly2025 Key Highlights & Daily Market Momentum Tracking - moha.gov.vn
Here's Why You Should Retain CONMED Stock in Your Portfolio Now - Finviz
Why Conmed (CNMD) is a Top Value Stock for the Long-Term - Yahoo Finance
Is There Now An Opportunity In CONMED Corporation (NYSE:CNMD)? - Yahoo Finance
Why CONMED Corporation stock could rally in 2025Forecast Cut & Proven Capital Preservation Methods - Улправда
Will CONMED Corporation stock outperform Nasdaq indexJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - Улправда
Published on: 2025-12-19 14:29:06 - DonanımHaber
Will Exiting Gastroenterology to Refocus on Core Surgery Change CONMED’s (CNMD) Margin Expansion Narrative? - simplywall.st
Is CONMED Corporation stock near bottom after declineJuly 2025 Analyst Calls & Trade Opportunity Analysis - Улправда
Why CONMED (CNMD) Stock Is Trading Up Today - Finviz
CONMED (CNMD) Valuation Review as It Exits Gastroenterology and Refocuses on Core Growth Areas - simplywall.st
Here's Why Conmed (CNMD) is a Strong Growth Stock - Yahoo Finance
Here's Why Conmed (CNMD) is a Strong Value Stock - Yahoo Finance
Oversold Conditions For CONMED (CNMD) - Nasdaq
CONMED (NYSE:CNMD) Price Target Lowered to $52.00 at Bank of America - Defense World
CONMED (NYSE:CNMD) Shares Little Changed After Operations Update - Kalkine Media
CONMED Stock Falls as It Strategically Exits Gastroenterology Portfolio - Yahoo Finance
Conmed to exit gastroenterology business - Yahoo Finance
Is CONMED (CNMD) Trading Niche Biliary Devices For A Higher-Margin Endoscopy Future? - Yahoo Finance
Looking at the Narrative for CONMED After Analyst Model Tweaks and Capital Moves - Yahoo Finance
How Conmed Corp.Ordinary Shares (CNMD) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Here's why you should add CONMED stock to your portfolio now - MSN
CONMED (NYSE:CNMD) Hits New 52-Week LowWhat's Next? - MarketBeat
CONMED (CNMD) Passes Through 2% Yield Mark - Nasdaq
CONMED to Exit Gastroenterology Market - Medical Product Outsourcing
CONMED to exit gastroenterology product lines as part of portfolio shift - Medical Economics
Why CONMED (CNMD) Shares Are Plunging Today - Finviz
Conmed stock hits 52-week low at 40.0 USD - Investing.com
Why Is Conmed (CNMD) Up 0.1% Since Last Earnings Report? - Yahoo Finance
Why Is Conmed Stock Falling Friday?Conmed (NYSE:CNMD) - Benzinga
Conmed to exit gastroenterology product lines, transfer Gore Viabil rights to Olympus - MassDevice
Conmed to conclude distribution agreement with W. L. Gore & Associates - TipRanks
Conmed to Exit Gastroenterology Product Lines, End Distribution Deal With Gore - marketscreener.com
Conmed to exit gastroenterology business, ends Gore distribution deal - Investing.com
Conmed to exit gastroenterology business, ends Gore distribution deal By Investing.com - Investing.com Canada
Conmed Exits Gastroenterology Products to Focus on Core Markets - TipRanks
CONMED Corp Announces Strategic Exit from Gastroenterology Product Lines - TradingView — Track All Markets
Conmed Corp announces exit from gastroenterology product lines - marketscreener.com
Conmed Announces Exclusive U.S. and Canadian Distribution Rights for the Gore® Viabil® Biliary Stent - marketscreener.com
Zacks.com featured highlights include Plains GP, Edison International, TD SYNNEX, CONMED and PG&E - sharewise.com
Here's Why You Should Add CONMED Stock to Your Portfolio Now - sharewise.com
Will CONMED Corporation stock keep outperforming rivals2025 Short Interest & Verified Technical Signals - Newser
Fisher Asset Management LLC Has $18.92 Million Holdings in CONMED Corporation $CNMD - Defense World
Why institutional investors increase stakes in CONMED Corporation stockWeekly Market Report & Daily Technical Stock Forecast Reports - Newser
Is CONMED Corporation stock overvalued by current metricsJuly 2025 Setups & Expert Verified Stock Movement Alerts - Newser
Can CONMED Corporation (EC8) stock sustain double digit ROEGlobal Markets & Technical Buy Zone Confirmations - Newser
Conmed Corp Stock (CNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):